The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness

Cornea

Volumn 30, Issue 8, 2011, Pages 861-864

  Zhong, Yisheng ^a   Shen, Xi ^a   Yu, Jun ^a   Tan, Haibo ^a   Cheng, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

bimatoprost; central corneal thickness; latanoprost; travoprost

Indexed keywords

BIMATOPROST; LATANOPROST; TRAVOPROST;

ADULT; ARTICLE; CORNEA THICKNESS; DRUG EFFECT; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; AMIDES; ANTIHYPERTENSIVE AGENTS; BODY WEIGHTS AND MEASURES; CLOPROSTENOL; CORNEA; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; TONOMETRY, OCULAR;

EID: 79960700507     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182000c27     Document Type: Article

References (28)

1. Inoue K, Okugawa K, Kato S, et al. Ocular factors relevant to antiglaucomatous eyedrop-related keratoepitheliopathy. J Glaucoma. 2003;12:480-485. (Pubitemid 37494176)
2. Kaminski S, Hommer A, Koyuncu D, et al. Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. Acta Ophthalmol Scand. 1998;76:78-79. (Pubitemid 28120603)
3. Liu Y, Yanai R, Lu Y, et al. Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts. J Glaucoma. 2006;15: 255-259.
4. Weizer JS, Stinnett SS, Herndon LW. Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study. Br J Ophthalmol. 2006;90:732-736. (Pubitemid 43835491)
5. Gaton DD, Sagara T, Lindsey JD, et al. Increased matrix metalloproteinase 1, 2 and 3 in the monkey uveoscleral outflow pathway following topical prostaglandin F 2a-isopropyl ester treatment. Arch Ophthalmol. 2001; 119:1165-1170. (Pubitemid 32730004)
6. Zhong Y, Gao J, Ye W, et al. Effect of latanoprost acid and pilocarpine on cultured rabbit ciliary muscle cells. Ophthalmic Res. 2007;39:232-240. (Pubitemid 47230702)
7. Wu KY, Wang HZ, Hong SJ. Effect of latanoprost on cultured porcine stromal cells. Curr Eye Res. 2005;30:871-879.
8. Harasymowycz P, Papamatheakis D, Ennis M, et al. Relationship between travoprost and central corneal thickness in ocular hypertension and openangle glaucoma. Cornea. 2007;26:34-41. (Pubitemid 46041561)
9. Sen E, Nalcacioglu P, Yazici A, et al. Comparison of the effects of latanoprost and bimatoprost on central corneal thickness. J Glaucoma. 2008;17:398-402.
10. Arcieri ES, Pierre Filho PTP, Wakamatsu TH, et al. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension. Eye. 2008;22:179-183. (Pubitemid 351266454)
11. Hatanaka M, Vessani RM, Elias IR, et al. The effect of prostaglandin analogs and prostamide on central corneal thickness. J Ocular Pharmacol Ther. 2009;25:51-53.
12. Bafa M, Georgopoulos G, Mihas C, et al. The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes. Acta Ophthalmol. 2009 [epub ahead of print] doi: 10.1111/j.1755-3768.2009.01731.x, PMID: 19878123.
13. Zhong Y, Chen L, Cheng Y, et al. Correlation between blue-on-yellow perimetry and GDx VCC measurements in primary open angle glaucoma. Jpn J Ophthalmol. 2009;53:574-579.
14. Choi J, Jeong J, Hyun-soo Cho H, et al. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci. 2006;47:831-836. (Pubitemid 46768313)
15. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary openangle glaucoma. Arch Ophthalmol. 2002;120:701-713. (Pubitemid 34620348)
16. Fogagnolo P, Capizzi F, Orzalesi N, et al. Can mean central corneal thickness and its 24-hour fluctuation influence fluctuation of intraocular pressure? J Glaucoma. 2009 [epub ahead of print] PMID: 1966 1818.
17. Wossner JFJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
18. Nagase H, Woessner JFJ. Matrix metalloproteinases. J Biol Chem. 1999; 274:21491-21494. (Pubitemid 129519680)
19. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle: a study on cultured cells and tissue sections. Exp Eye Res. 1998; 67:179-191. (Pubitemid 28428266)
20. Weinreb RN, Kashiwagi K, Kashiwagi F, et al. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997;38:2772-2780. (Pubitemid 28009399)
21. Maeda M, Vanlandingham BD, Ye H, et al. Immunoconfocal localization of gelatinase B expressed by migrating intrastromal epithelial cells after deep annular excimer keratectomy. Curr Eye Res. 1998;17:836-843. (Pubitemid 28388930)
22. Chang JH, Kook MC, Lee JH, et al. Effects of synthetic inhibitor of metalloproteinase and cyclosporine A on corneal haze after excimer laser photorefractive keratectomy in rabbits. Exp Eye Res. 1998;66:348-396.
23. Garrana RM, Zieske JD, Assouline M. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest Ophthalmol Vis Sci. 1999;40:1266-1270. (Pubitemid 29211467)
24. Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997;41:275-313. (Pubitemid 27152682)
25. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci. 1990;31: 1779-1788. (Pubitemid 20350902)
26. Viestenz A, Martus P, Schlötzer-Schrehardt U, et al. Impact of prostaglandin-F (2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness-a cross-sectional study on 403 eyes. Klin Monatsbl Augenheilkd. 2004;221:753-756. (Pubitemid 39390855)
27. Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol. 1975;53:34-43.
28. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44:367-408. (Pubitemid 30151145)